Ligand Pharmaceuticals: Attractive Royalty Model Powers Forward
Core Insights - The article discusses the author's perspective on investing as a learning process, emphasizing that both successes and failures contribute to valuable lessons learned in the investment journey [1]. Company Insights - The focus is on Ligand Pharmaceuticals (NASDAQ: LGND), highlighting its strong growth potential and the opportunity to gain exposure to numerous therapies through investment in the company [1]. Analyst's Position - The author has a beneficial long position in Ligand Pharmaceuticals and Gilead Sciences (GILD), indicating confidence in the future performance of these stocks [2].